From asset purchases tied to CHOW approval to SBA-financed buyouts with seller earnouts — learn how deals are structured in this highly regulated, cash-flowing industry.
Acquiring a Medicare-certified home health agency involves deal structures that go well beyond a standard business purchase. Every transaction must account for the CMS Change of Ownership (CHOW) process, payor re-enrollment timelines, billing compliance risk, and staff retention — all of which directly affect how money flows at close and over the post-acquisition period. Most home health agency deals in the $1M–$5M revenue range are structured as either asset purchases or stock purchases, with financing layered from SBA 7(a) loans, seller notes, and equity injections. Earnouts and holdbacks tied to patient census retention and CHOW completion are common tools used to bridge valuation gaps and allocate regulatory risk between buyer and seller. Understanding these mechanics is essential whether you are a nurse practitioner buying your first agency, a regional operator expanding geographically, or a PE-backed platform executing a roll-up strategy.
Find Home Health Agency Businesses For SaleAsset Purchase with CHOW Holdback
The buyer acquires specific assets of the home health agency — including the Medicare and Medicaid certifications, patient records, equipment, and referral relationships — while the seller retains liabilities. A portion of the purchase price (typically 10–15%) is held in escrow until the CMS Change of Ownership is fully approved and the buyer is re-enrolled with all payors. This is the most common structure in home health acquisitions because it limits the buyer's exposure to pre-closing billing compliance violations and unresolved survey deficiencies.
Pros
Cons
Best for: First-time buyers or individual investors acquiring a single Medicare-certified agency who want protection against pre-closing billing exposure and regulatory surprises during the CHOW period.
Stock Purchase with Seller Earnout
The buyer acquires 100% of the equity in the legal entity that holds the Medicare certification, state licensure, and all payor contracts. This avoids triggering a formal CHOW with CMS in some structures (consult healthcare M&A counsel), but the buyer inherits all historical liabilities. An earnout is layered on top of the base purchase price, with additional payments contingent on the agency maintaining a defined patient census threshold or revenue level for 12–24 months post-close. This structure is common in PE roll-up acquisitions and strategic acquisitions between regional operators.
Pros
Cons
Best for: Strategic acquirers and PE-backed platforms with experienced healthcare compliance teams who can conduct deep pre-close diligence and absorb or insure against inherited regulatory liability in exchange for a faster close and continuity of payor contracts.
SBA 7(a) Financed Acquisition with Seller Note
The buyer finances the majority of the acquisition through an SBA 7(a) loan, which can cover up to 90% of the total project cost for eligible home health agency transactions. The seller carries a subordinated note for 10–15% of the purchase price, which is required to be on full standby for the first 24 months of the SBA loan. The buyer injects 10% equity. This structure is widely used by individual buyers including clinicians, healthcare administrators, and first-time business owners acquiring cash-flowing, Medicare-certified agencies that qualify under SBA guidelines.
Pros
Cons
Best for: Individual buyers — including nurse practitioners, physical therapists, and healthcare administrators — acquiring a single Medicare-certified home health agency with $1M–$5M in revenue and proven EBITDA margins sufficient to service SBA debt.
Individual Buyer — SBA Financed Asset Purchase of a Medicare-Certified Agency
$1,800,000
$1,350,000 SBA 7(a) loan (75%), $270,000 seller note at 6% over 7 years on 24-month standby (15%), $180,000 buyer equity injection (10%)
Asset purchase structure. 10% holdback ($180,000) held in escrow pending CHOW approval and Medicare re-enrollment, released at 180 days post-close. Seller note begins amortizing at month 25. Seller agrees to a 90-day transition consulting period to support referral source introductions and staff retention. Earnout waived in exchange for seller cooperation on CHOW.
PE-Backed Roll-Up Platform — Stock Purchase with Earnout
$4,200,000
$3,360,000 paid at close (80% of purchase price funded through platform credit facility), $840,000 earnout structured over 24 months post-close (20%)
Stock purchase of 100% of entity equity. Earnout paid in two tranches: $420,000 at month 12 if active patient census remains above 85 patients and trailing twelve-month revenue exceeds $2.1M; $420,000 at month 24 if census remains above 90 patients and revenue exceeds $2.2M. Representations and warranties insurance obtained at buyer's cost. Seller enters 24-month non-compete covering county of operation. Billing compliance escrow of $200,000 held for 18 months to cover any pre-close CMS overpayment demands.
Regional Operator — Asset Purchase with Holdback and Partial Seller Financing
$2,500,000
$1,750,000 conventional bank loan (70%), $375,000 seller note at 6.5% over 5 years (15%), $250,000 CHOW holdback in escrow (10%), $125,000 buyer equity (5%)
Asset purchase. Holdback of $250,000 released in two equal tranches: $125,000 upon confirmed CMS CHOW approval and $125,000 upon re-enrollment with all Medicaid managed care payors, each within 180 days of close. Seller note begins amortizing at month 7. Seller provides 60-day operational transition with introductions to top five hospital discharge planners and physician referral sources. Key RN clinical director retained under a two-year employment agreement signed at close.
Find Home Health Agency Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
A Change of Ownership (CHOW) is the formal CMS process required when ownership of a Medicare-certified home health agency transfers to a new entity or individual through an asset purchase. The buyer must submit a new Medicare enrollment application (CMS-855A), and during the review period — which typically takes 90–180 days — the new owner may operate under a provisional billing number. Most deal structures account for this by using escrow holdbacks tied to CHOW completion and by ensuring the seller retains Medicare billing rights through a management services agreement until re-enrollment is confirmed. Stock purchases can sometimes avoid triggering a formal CHOW if the legal entity does not change, but buyers should consult a healthcare M&A attorney to confirm the structure's compliance implications.
Home health agencies with $1M–$5M in revenue and healthy Medicare/Medicaid certification histories typically transact at 3.5x–6x EBITDA in the lower middle market. Agencies commanding the higher end of that range generally have strong CMS star ratings (4+ stars), diversified payor mixes with meaningful private pay or managed care revenue, clean compliance histories, census of 75–150+ active patients, and documented referral relationships that are institutional rather than owner-dependent. Agencies with concentration risk, open CMS audits, high staff turnover, or heavy owner dependency will trade at the lower end or require significant seller concessions in the deal structure.
Yes. Home health agencies are eligible for SBA 7(a) loans, which are commonly used by individual buyers to finance acquisitions in the $1M–$5M revenue range. SBA loans can cover up to 90% of the total project cost, including the purchase price and working capital, with loan terms of up to 10 years for business acquisitions. Because Medicare reimbursement provides predictable monthly cash flows, home health agencies often present favorably in SBA underwriting. Buyers should note that SBA lenders will require the seller note to be on full standby for at least 24 months, and that CHOW timing must be coordinated carefully with SBA loan disbursement to avoid gaps in Medicare billing authority.
Earnouts are used in home health acquisitions primarily to bridge valuation gaps created by regulatory and operational uncertainty. Sellers believe their patient census, referral relationships, and reimbursement rates will hold post-close; buyers are concerned about CHOW disruptions, staff turnover, or referral source attrition after the owner departs. An earnout allows both parties to share in that risk by tying a portion of the purchase price to measurable post-close outcomes — most commonly active patient census thresholds, payor mix maintenance, or trailing revenue levels at 12 and 24 months. Earnout periods beyond 24 months are uncommon in this industry given the pace of reimbursement model changes under PDGM.
Pre-closing CMS overpayment demands — including those arising from RAC audits, ZPIC reviews, or routine claims audits — are one of the most significant post-close liability risks in home health acquisitions. In an asset purchase, the buyer generally does not inherit pre-closing billing liabilities, but sellers may have limited resources to satisfy large demands. In a stock purchase, the buyer inherits all pre-closing liabilities. The most effective protections include a thorough pre-close billing compliance audit, a dedicated indemnification escrow held for 18–24 months post-close, strong seller representations and warranties, and representations-and-warranties insurance for larger transactions. Buyers should never waive a billing compliance audit regardless of deal timeline pressure.
In an asset purchase, managed care contracts — including Medicare Advantage, Medicaid managed care, and commercial insurance agreements — do not automatically transfer to the buyer. Each contract must be renegotiated or assigned with the explicit approval of the payor, which can take 60–120 days per contract and may result in rate or credentialing changes. This is a critical due diligence item because managed care revenue can represent 20–40% of a home health agency's total revenue. In a stock purchase, contracts remain in the entity and generally do not require reassignment, which is one of the primary reasons PE-backed buyers often prefer stock purchase structures for agencies with valuable managed care relationships.
More Home Health Agency Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers